This photograph taken on March 5, 2021 shows the flag of the World Health Organization (WHO) at their headquarters in Geneva amid the Covid-19 coronavirus outbreak. (Photo by Fabrice COFFRINI / AFP) (Photo by FABRICE COFFRINI/AFP via Getty Images)
A report from the Department of Energy on the origins of COVID-19 has agencies divided about its findings.
A classified intelligence report from the Energy Department alleges, with low confidence, that the virus likely leaked from a lab in China — a theory that was raised during the early days of the pandemic. How the agency went about drawing that conclusion has not been revealed to the public but is reportedly based on new information.
Meanwhile, a World Health Organization's investigation is ongoing, but the organization said that as more time passes, coupled with complications in completing studies in China, that it will be more difficult to pinpoint the exact origin of the virus.
In light of the report, the White House national security adviser, Jake Sullivan, told CNN that the Department of Energy's findings offer "no definitive answer" about the origins of COVID.
"There is a variety of views in the intelligence community. Some elements in the intelligence community have reached conclusions on one side, some on the other. A number of them have just said they don't have enough information to be sure," he said.
China's foreign ministry spokesperson Mao Ning has dismissed the allegations altogether and said, "The origins tracing of SARS-CoV-2 is about science and should not be politicized."
"Certain parties should stop rehashing the 'lab leak' narrative, stop smearing China and stop politicizing origins-tracing," Ning added.
The FBI drew a similar conclusion in 2021, but the CIA is among the U.S. intelligence agencies that have not reached a conclusion.
An FDA panel has recommended the low-dose Pfizer vaccine for kids ages five to 11. The recommendation now cues up the FDA to authorize the vaccine. Next week, the CDC will consider its own authorization. Once signed off by the CDC, the Pfizer vaccine can be administered in children immediately. Dr. Christina Johns, Senior Medical Advisor at PM Pediatrics, joined Cheddar's Search for a Cure.
Dr. Vivek Cherin, Internal Medicine Physician at Amita Health, joined Cheddar's Search for a Cure to break down what we need to know about eligibility and availability of COVID-19 vaccine boosters.
World leaders will converge this weekend at the 2021 G20 Summit in Rome and the UN COP26 conference in Glasgow with the climate crisis on the agenda. Lord Adair Turner, chair of the Energy Transitions Commission, joined Cheddar to discuss what people can expect to come out of the climate-focused conferences. Turner also noted that one of the biggest hurdles for the attending nations will be coming to a uniform decision on expanding on the Paris Climate Accord goals that have become insufficient to prevent global warming by 1.5 degrees celsius.
Nicole Lambert, President at Myriad Genetics joins ChedHER to discuss how to expand access to genetic testing for all women, and how her experience as a 'pre-vivor' motivates her role in the industry.
Carlo and Baker cover Facebook's big rebrand, the latest on Biden's economic agenda and more. Plus, ranking the best Halloween candy and the worst couple's costumes.
Proptech startup Juno recently raised $20 million in a Series A funding round. The company says the funds will be used to further its mission of building sustainable and affordable apartment buildings across the United States. Juno Co-Founder and CEO Jonathan Sherr joined Cheddar News' Closing Bell to discuss.
Stacey Stevens, President of iCAD, joins 'Cheddar Innovates' to discuss how 'Profound A.I. Risk' works as a short-term breast cancer risk estimation for women.
On this episode of 'Cheddar Innovates': President of iCAD breaks down how its technology is being used as a short-term breast cancer risk estimation for women; A look at Curiosity Stream's 'The Science of Thrills.'
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.
